Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution

被引:6
|
作者
Fernandez-Munoz, Hermogenes [1 ,2 ]
Castilla-Llorente, Cristina [1 ,3 ]
Plaza, Eva M. [1 ]
Martinez-Millan, Cristina [1 ]
Heras, Inmaculada [1 ]
Iniesta, Pastora [1 ]
Amigo, Maria L. [1 ]
Ferrer-Marin, Francisca [1 ]
Candela, Maria J. [1 ]
Lozano, Maria L. [1 ]
Vicente, Vicente [1 ]
Rivera, Jose [1 ]
机构
[1] Univ Murcia, Morales Meseguer Univ Hosp, Reg Blood Donat Ctr, Haematol & Med Oncol Serv,IMIB Arrixaca,CIBERER, Murcia, Spain
[2] Rafael Mendez Univ Hosp, Haematol & Blood Therapy Serv, Lorca, Spain
[3] Gustave Roussy Inst, Haematol Serv, Villejuif, France
关键词
washed platelet concentrates; washed platelet function; washed platelet transfusion; VerifyNow (R) system; IN-VITRO QUALITY; WASHING PLATELETS; STORAGE; SYSTEM; REFRACTORINESS; APHERESIS; REMOVAL;
D O I
10.2450/2017.0277-16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Transfusion of washed platelet concentrates (W-PC) is recommended for some patients, such as those who have had previous severe allergic transfusion reactions. However, we still lack a standardised method for preparing these products. Here, we assessed the effect of a manual washing procedure on in vitro platelet quality and on the transfusion efficacy of W-PCs. Materials and methods. Buffy coat-derived W-PC in Composol solution were prepared by one-step centrifugation. Platelet activation and function were evaluated before and after washing by means of: (i) CD62 expression by flow cytometry; (ii) platelet aggregation (LTA); and (iii) the VerifyNow (R) P2Y12 test. A pilot prospective transfusion study was carried out in 11 onco-hematology patients receiving, in a short time, two consecutive transfusions: one with standard PC (S-PC) and one with W-PC. The post-transfusion platelet increment, the 1 h and 24 h corrected count increment (CCI) and occurrence of bleeding events were used as indices of transfusion efficacy. Results. Platelet recovery in W-PC was 84.8 +/- 5.4%. Washing slightly increased platelet activation in W-PC vs pre-washed samples (% CD62+ platelets 23.6 +/- 7 vs 14.8 +/- 1; p=0.03). As compared to prewash samples, platelet reactivity of W-PC as measured by VerifyNow (R) P2Y12 was significantly lower with ADP (PRU 32.2 +/- 37.7 vs 4.2 +/- 2.4, p=0.027), but similar using TRAP. Platelet aggregation responses to TRAP, collagen, ristocetin and arachidonic acid were maintained in W-PC. The pilot transfusion trial showed similar 1 h (13.5 +/- 5.6 vs 11.5 +/- 7.3, p=0.49) and 24 h (11 +/- 7.2 vs 9 +/- 6.5, p=0.48) CCI for S-PC and W-PC. Transfusion of W-PC was not associated with an increased number of bleeding events. Discussion. We have set up a simple method to obtain buffy-coat-derived W-PC, which has minor effects on in vitro platelet quality and transfusion effectiveness. This procedure can be easily implemented in transfusion centres for on-demand preparation of washed platelets.
引用
下载
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [31] ADVERSE REACTIONS TO PLATELET TRANSFUSIONS ARE REDUCED BY USE OF PLATELET CONCENTRATES DERIVED FROM BUFFY COAT
    OKSANEN, K
    EBELING, F
    KEKOMAKI, R
    ELONEN, E
    SAHLSTEDT, L
    VOLIN, L
    MYLLYLA, G
    VOX SANGUINIS, 1994, 67 (04) : 356 - 361
  • [32] Effect of L-carnitine during storage of buffy-coat platelet concentrates in an additive solution
    Aleil, B
    Isola, H
    Cazenave, JP
    VOX SANGUINIS, 2005, 89 (01) : 59 - 60
  • [33] COMPARISON OF SOLUBLE CD40L IN APHERESIS AND BUFFY COAT-DERIVED PLATELET CONCENTRATES DURING 7 DAYS STORAGE
    Xie, R. F.
    Yang, J.
    Ren, Y.
    Fan, H. H.
    VOX SANGUINIS, 2011, 101 : 26 - 26
  • [34] IN VITRO QUALITY TEST OF PLATELET CONCENTRATES FROM BUFFY COAT AND APHERESIS IN ADDITIVE SOLUTION, TREATED WITH TWO PATHOGEN INACTIVATION SYSTEMS
    Castrillo, A.
    Arcas, C.
    Castro, A.
    Eiras, A.
    Adelantado, M.
    Areal, C.
    Rodriguez, M., I
    VOX SANGUINIS, 2010, 99 : 249 - 250
  • [35] Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
    Schrezenmeier, H.
    Seifried, E.
    VOX SANGUINIS, 2010, 99 (01) : 1 - 15
  • [36] Platelet storage lesion of WBG-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations
    Krailadsiri, P
    Seghatchian, J
    Williamson, LM
    TRANSFUSION, 2001, 41 (02) : 243 - 250
  • [37] THE EFFICACY AND EFFICIENCY PLATELET TRANSFUSION IN BUFFY COAT PLATELET COMPONENTS TREATED OR NOT BY INTERCEPT BLOOD SYSTEM
    Belkaid, M. I.
    Bakiri, N.
    Tsaramaro, M.
    Brochier, G.
    Chirpaz, E.
    Schooneman, F.
    Henni, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 286 - 286
  • [38] Fully automated processing of buffy-coat-derived pooled platelet concentrates
    Janetzko, K
    Klüter, H
    van Waeg, G
    Eichler, H
    TRANSFUSION, 2004, 44 (07) : 1052 - 1058
  • [39] Platelet concentrates derived from buffy coat and apheresis:: biochemical and functional differences
    Böck, M
    Rahrig, S
    Kunz, D
    Lutze, G
    Heim, MU
    TRANSFUSION MEDICINE, 2002, 12 (05) : 317 - 324
  • [40] Comparison between the clinical efficacy of platelet concentrates, derived from buffy coat and apheresis in tumor patients
    Hao, Baolan
    Wang, Yan
    Zhou, Jian
    Shao, Shujun
    Dong, Xiaofeng
    ONCOLOGY LETTERS, 2017, 14 (02) : 1445 - 1448